AUTOIMMUNE HYPOTHYROIDISM

This adverse event was reported 238 times

These drugs are most commonly taken by patients reporting AUTOIMMUNE HYPOTHYROIDISM:

# Drug Count
0 PEMBROLIZUMAB 84
1 NIVOLUMAB 40
2 CARBOPLATIN 28
3 ALEMTUZUMAB 24
4 IPILIMUMAB 22
5 PACLITAXEL 19
6 PACLITAXEL (AIBUMIN-BOUND) 18
7 TRASTUZUMAB 16
8 CISPLATIN 15
9 CAPECITABINE 14
See all common drugs associated with AUTOIMMUNE HYPOTHYROIDISM

AUTOIMMUNE HYPOTHYROIDISM is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CASTOR OIL 2 0.0104
1 TALIGLUCERASE ALFA 1 0.0017
2 TALIMOGENE LAHERPAREPVEC 2 0.0013
3 ALEMTUZUMAB 24 0.0012
4 CLINDAMYCIN PHOSPHATE 6 0.0011
5 DOSTARLIMAB 2 0.0008
6 ALDESLEUKIN 1 0.0008
7 FINGOLIMOD HYDROCHLORIDE 4 0.0008
8 PEMBROLIZUMAB 84 0.0008
9 ROPEGINTERFERON ALFA-2B 1 0.0005
See all drugs enriched for association with AUTOIMMUNE HYPOTHYROIDISM